{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T02:11:30Z","timestamp":1784945490294,"version":"3.55.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T00:00:00Z","timestamp":1669939200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.biopha.2022.114088","type":"journal-article","created":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T03:06:17Z","timestamp":1670468777000},"page":"114088","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Inhibition of proliferative vitreoretinopathy by a newly developed methotrexate loaded drug carrier in vitro"],"prefix":"10.1016","volume":"158","author":[{"given":"Sebastian S.","family":"Arrow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone C.","family":"Felis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Hillenmayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura D.","family":"Strehle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna F.","family":"Koenig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efstathios","family":"Vounotrypidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armin","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian M.","family":"Wertheimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2022.114088_bib1","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1159\/000438972","article-title":"Retinal detachment and proliferative vitreoretinopathy","volume":"55","author":"Kwon","year":"2016","journal-title":"Dev. Ophthalmol."},{"key":"10.1016\/j.biopha.2022.114088_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajo.2022.02.028","article-title":"Factors associated with good visual acuity outcomes after retinectomy in eyes with proliferative vitreoretinopathy","author":"Israilevich","year":"2022","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.biopha.2022.114088_bib3","doi-asserted-by":"crossref","DOI":"10.1136\/bmjophth-2019-000293","article-title":"Intravitreal methotrexate for the treatment of proliferative vitreoretinopathy","volume":"4","author":"Benner","year":"2019","journal-title":"BMJ Open Ophthalmol."},{"key":"10.1016\/j.biopha.2022.114088_bib4","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1159\/000500271","article-title":"Repeated injection of methotrexate into silicone oil-filled eyes for grade C proliferative vitreoretinopathy: a pilot study","volume":"242","author":"Nourinia","year":"2019","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.biopha.2022.114088_bib5","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1080\/09273948.2019.1597894","article-title":"Intra-silicone oil injection of methotrexate in retinal reattachment surgery for proliferative vitreoretinopathy","volume":"28","author":"Falavarjani","year":"2020","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.biopha.2022.114088_bib6","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.2147\/OPTH.S209395","article-title":"Dexamethasone intravitreal implant for the treatment of macular edema and uveitis: a comprehensive narrative review","volume":"16","author":"Kishore","year":"2022","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.biopha.2022.114088_bib7","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1080\/17425247.2016.1227785","article-title":"Extended ocular drug delivery systems for the anterior and posterior segments: biomaterial options and applications","volume":"14","author":"Kang-Mieler","year":"2017","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.biopha.2022.114088_bib8","doi-asserted-by":"crossref","first-page":"6408","DOI":"10.1167\/iovs.17-22555","article-title":"The intraocular lens as a drug delivery device: in vitro screening of pharmacologic substances for the prophylaxis of posterior capsule opacification","volume":"58","author":"Wertheimer","year":"2017","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.biopha.2022.114088_bib9","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1001\/archopht.119.10.1518","article-title":"Pharmacokinetics and toxicity of intravitreal chemotherapy for primary intraocular lymphoma","volume":"119","author":"Velez","year":"2001","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.biopha.2022.114088_bib10","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1001\/archopht.119.10.1518","article-title":"Pharmacokinetics and toxicity of intravitreal chemotherapy for primary intraocular lymphoma","volume":"119","author":"Velez","year":"2001","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.biopha.2022.114088_bib11","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.3390\/polym3031377","article-title":"Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier","volume":"3","author":"Makadia","year":"2011","journal-title":"Polymers"},{"key":"10.1016\/j.biopha.2022.114088_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12030269","article-title":"Drug delivery to the posterior segment of the eye: biopharmaceutic and pharmacokinetic considerations","volume":"12","author":"Varela-Fernandez","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2022.114088_bib13","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/IIO.0000000000000258","article-title":"Proliferative vitreoretinopathy: a review","volume":"59","author":"Idrees","year":"2019","journal-title":"Int. Ophthalmol. Clin."},{"key":"10.1016\/j.biopha.2022.114088_bib14","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.survophthal.2012.12.004","article-title":"Pathophysiology of proliferative vitreoretinopathy in retinal detachment","volume":"58","author":"Garweg","year":"2013","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.biopha.2022.114088_bib15","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1007\/s00417-017-3767-x","article-title":"A cell culture technique for human epiretinal membranes to describe cell behavior and membrane contraction in vitro","volume":"255","author":"Wertheimer","year":"2017","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.biopha.2022.114088_bib16","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1007\/s00417-018-4033-6","article-title":"Premacular membranes in tissue culture","volume":"256","author":"Vogt","year":"2018","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.biopha.2022.114088_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0146887","article-title":"Epithelial-to-mesenchymal transition of RPE cells in vitro confers increased beta1,6-N-glycosylation and increased susceptibility to galectin-3 binding","volume":"11","author":"Priglinger","year":"2016","journal-title":"PLOS One"},{"key":"10.1016\/j.biopha.2022.114088_bib18","first-page":"1325","article-title":"Proliferative vitreoretinopathy: current and emerging treatments","volume":"6","author":"Sadaka","year":"2012","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.biopha.2022.114088_bib19","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1021\/cr940351u","article-title":"Polymeric systems for controlled drug release","volume":"99","author":"Uhrich","year":"1999","journal-title":"Chem. Rev."},{"key":"10.1016\/j.biopha.2022.114088_bib20","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1007\/s00417-016-3350-x","article-title":"Retinal vein occlusion and the use of a dexamethasone intravitreal implant (Ozurdex(R)) in its treatment","volume":"254","author":"Garweg","year":"2016","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.biopha.2022.114088_bib21","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s40005-019-00439-x","article-title":"Biocompatibility, biodegradation and biomedical applications of poly(lactic acid)\/poly(lactic-co-glycolic acid) micro and nanoparticles","volume":"49","author":"Elmowafy","year":"2019","journal-title":"J. Pharm. Investig."},{"key":"10.1016\/j.biopha.2022.114088_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13081227","article-title":"Pharmacokinetics and toxicity evaluation of a PLGA and chitosan-based micro-implant for sustained release of methotrexate in rabbit vitreous","volume":"13","author":"Manna","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2022.114088_bib23","doi-asserted-by":"crossref","first-page":"178","DOI":"10.31768\/2312-8852.2018.40(3):178-183","article-title":"Role of dendrimers in advanced drug delivery and biomedical applications: a review","volume":"40","author":"Akbarzadeh","year":"2018","journal-title":"Exp. Oncol."},{"key":"10.1016\/j.biopha.2022.114088_bib24","doi-asserted-by":"crossref","first-page":"4727","DOI":"10.2147\/IJN.S168053","article-title":"Recent advances in \"smart\" delivery systems for extended drug release in cancer therapy","volume":"13","author":"Kalaydina","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2022.114088_bib25","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ijbiomac.2019.08.119","article-title":"The effect of hyaluronic acid hydrogels on dental pulp stem cells behavior","volume":"140","author":"Ahmadian","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.biopha.2022.114088_bib26","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1076\/ocii.11.2.79.15918","article-title":"Methotrexate in inflammatory eye disease","volume":"11","author":"Stawell","year":"2003","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.biopha.2022.114088_bib27","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.ajo.2006.06.002","article-title":"Intraocular methotrexate in ocular diseases other than primary central nervous system lymphoma","volume":"142","author":"Hardwig","year":"2006","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.biopha.2022.114088_bib28","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1097\/ICO.0b013e3182910106","article-title":"Toxic corneal epitheliopathy after intravitreal methotrexate and its treatment with oral folic acid","volume":"32","author":"Gorovoy","year":"2013","journal-title":"Cornea"},{"key":"10.1016\/j.biopha.2022.114088_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9082672","article-title":"Corneal epithelial toxicity after intravitreal methotrexate injection for vitreoretinal lymphoma: clinical and in vitro studies","volume":"9","author":"Jeong","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.biopha.2022.114088_bib30","article-title":"Successful treatment of anterior segment fibrosis with intravitreal methotrexate","volume":"25","author":"Ahmad","year":"2022","journal-title":"Am. J. Ophthalmol. Case Rep."},{"key":"10.1016\/j.biopha.2022.114088_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12886-020-01464-3","article-title":"Reduced frequency of Intravitreal methotrexate injection lowers the risk of keratopathy in vitreoretinal lymphoma patients","volume":"20","author":"Zhou","year":"2020","journal-title":"BMC Ophthalmol."},{"key":"10.1016\/j.biopha.2022.114088_bib32","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.2147\/OPTH.S81218","article-title":"An outbreak of Ralstonia pickettii endophthalmitis following intravitreal methotrexate injection","volume":"9","author":"Choudhury","year":"2015","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.biopha.2022.114088_bib33","first-page":"595","article-title":"Intravitreal methotrexate for treatment of uveitic cystoid macular edema","volume":"115","author":"Maa\u00df","year":"2018","journal-title":"der Ophthalmol.: Z. der Dtsch. Ophthalmol. Ges."},{"key":"10.1016\/j.biopha.2022.114088_bib34","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1097\/IAE.0b013e3181754231","article-title":"The safety of intraocular methotrexate in silicone-filled eyes","volume":"28","author":"Hardwig","year":"2008","journal-title":"Retina"},{"key":"10.1016\/j.biopha.2022.114088_bib35","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/01480545.2017.1289221","article-title":"Methotrexate induced mitochondrial injury and cytochrome c release in rat liver hepatocytes","volume":"41","author":"Al Maruf","year":"2018","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.biopha.2022.114088_bib36","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.biopha.2018.08.050","article-title":"Mitochondrial dysfunction and oxidative stress are involved in the mechanism of methotrexate-induced renal injury and electrolytes imbalance","volume":"107","author":"Heidari","year":"2018","journal-title":"Biomed. Pharmcother."},{"key":"10.1016\/j.biopha.2022.114088_bib37","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3389\/fphar.2019.00119","article-title":"Protective effects of magnesium glycyrrhizinate on methotrexate-induced hepatotoxicity and intestinal toxicity may be by reducing COX-2","volume":"10","author":"Cao","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2022.114088_bib38","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/MPG.0b013e318247240d","article-title":"Methotrexate modulates tight junctions through NF-kappaB, MEK, and JNK pathways","volume":"54","author":"Beutheu Youmba","year":"2012","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.biopha.2022.114088_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.pestbp.2020.104586","article-title":"Effects of quercetin loaded nanostructured lipid carriers on the paraquat-induced toxicity in human lymphocytes","volume":"167","author":"Ahmadian","year":"2020","journal-title":"Pest. Biochem. Physiol."},{"key":"10.1016\/j.biopha.2022.114088_bib40","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1600-0420.2004.00317.x","article-title":"Ascorbic acid reversibly inhibits proliferation of retinal pigment epithelial cells","volume":"82","author":"Heckelen","year":"2004","journal-title":"Acta Ophthalmol. Scand."},{"key":"10.1016\/j.biopha.2022.114088_bib41","doi-asserted-by":"crossref","first-page":"343","DOI":"10.4155\/tde-2019-0024","article-title":"Dexamethasone intravitreal implant (OZURDEX((R))) for macular edema secondary to noninfectious uveitis: a review of the literature","volume":"10","author":"Massa","year":"2019","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.biopha.2022.114088_bib42","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.1167\/iovs.16-21334","article-title":"Evaluation of the toxicity of intravitreally injected PLGA microspheres and rods in monkeys and rabbits: effects of depot size on inflammatory response","volume":"58","author":"Thackaberry","year":"2017","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.biopha.2022.114088_bib43","doi-asserted-by":"crossref","first-page":"9433","DOI":"10.1039\/D1RA00074H","article-title":"Cytotoxicity of targeted PLGA nanoparticles: a systematic review","volume":"11","author":"Chiu","year":"2021","journal-title":"RSC Adv."},{"key":"10.1016\/j.biopha.2022.114088_bib44","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1097\/IAE.0000000000003472","article-title":"Long-term efficacy of fluocinolone in eyes with iris-lens diaphragm disruption and pcme with medication fixed in the sclera (Mefisto)","volume":"42","author":"Herold","year":"2022","journal-title":"Retina"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222014779?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222014779?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T11:36:24Z","timestamp":1779795384000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332222014779"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":44,"alternative-id":["S0753332222014779"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2022.114088","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of proliferative vitreoretinopathy by a newly developed methotrexate loaded drug carrier in vitro","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2022.114088","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"114088"}}